Wednesday, October 1, 2014

What can patient input do for clinical trial design?

Many clinical trials do not receive enough registrants - therefore they cannot be completed. If a recent piece at the Wall Street Journal, they take a look at the new movement to include patients in the design of the clinical trials. In this piece, Brandy Parker-McFadden shares how she has contributed to the design of an epilepsy trial for children. This allows patients to contribute their side of the drug: what they want and need from a drug and how it is affecting them.

One of the main concerns of the designers is how long it could take to design the trials. But would the trade off be equal if patients were a contributing their insights and needs to the companies as they were designing clinical trials?

Watch the video here:

On October 15, we're teaming up with BBK Worldwide to present Patient-centric to the Core: Setting a New Standard for Engagement Strategies in Clinical Research. Join Matt Kibby, Principal, Technology & Innovation, BBK Worldwide as he examines the need for patient centricity in clinical trial. Register here and mention code XP2000W2BLOG.

No comments: